These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21494716)

  • 21. Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography.
    Hashii N; Kawasaki N; Itoh S; Qin Y; Fujita N; Hattori T; Miyata K; Bando A; Sekimoto Y; Hama T; Kashimura M; Tatsumi M; Mabuchi K; Namekawa H; Sakai T; Hirose M; Dobashi S; Shimahashi H; Koyama S; Herr SO; Kawai K; Yoden H; Yamaguchi T
    Biologicals; 2010 Sep; 38(5):539-43. PubMed ID: 20452241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Capillary electrophoresis analysis of contaminants in heparin sodium for the Japanese pharmacopoeia purity test].
    Kakoi N; Kinoshita M; Kawasaki N; Yamaguchi T; Hayakawa T; Kakehi K
    Yakugaku Zasshi; 2009 Oct; 129(10):1255-64. PubMed ID: 19797882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.
    McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R
    J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of currently marketed heparin products: key tests for LMWH quality assurance.
    Ye H; Toby TK; Sommers CD; Ghasriani H; Trehy ML; Ye W; Kolinski RE; Buhse LF; Al-Hakim A; Keire DA
    J Pharm Biomed Anal; 2013 Nov; 85():99-107. PubMed ID: 23917037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and purity test of heparin by NMR - a summary of two years' experience at the Medical Products Agency.
    McEwen I; Amini A; Olofsson IM
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):65-72. PubMed ID: 20223191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case study: contamination of heparin with oversulfated chondroitin sulfate.
    Chess EK; Bairstow S; Donovan S; Havel K; Hu P; Johnson RJ; Lee S; McKee J; Miller R; Moore E; Nordhaus M; Ray J; Szabo C; Wielgos T
    Handb Exp Pharmacol; 2012; (207):99-125. PubMed ID: 22566223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broadening of 1H NMR signals in the spectra of heparin and OSCS by paramagnetic transition metal ions. The use of EDTA to sharpen the signals.
    McEwen I
    J Pharm Biomed Anal; 2010 Feb; 51(3):733-5. PubMed ID: 19782493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel and highly sensitive mixed-polymeric electrokinetic chromatography system for determination of contaminants and impurities of heparin samples.
    Tripodi V; Flor S; Dobrecky C; Contin M; Lucangioli S
    Electrophoresis; 2010 Oct; 31(21):3606-12. PubMed ID: 20967770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
    Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
    Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.
    Zhang Z; Li B; Suwan J; Zhang F; Wang Z; Liu H; Mulloy B; Linhardt RJ
    J Pharm Sci; 2009 Nov; 98(11):4017-26. PubMed ID: 19642166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of impurities in heparin by capillary electrophoresis using high molarity phosphate buffers.
    Wielgos T; Havel K; Ivanova N; Weinberger R
    J Pharm Biomed Anal; 2009 Feb; 49(2):319-26. PubMed ID: 19155153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Ca2+ on the 1H NMR chemical shift of the methyl signal of oversulphated chondroitin sulphate, a contaminant in heparin.
    McEwen I; Rundlöf T; Ek M; Hakkarainen B; Carlin G; Arvidsson T
    J Pharm Biomed Anal; 2009 Apr; 49(3):816-9. PubMed ID: 19179033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products.
    Bairstow S; McKee J; Nordhaus M; Johnson R
    Anal Biochem; 2009 May; 388(2):317-21. PubMed ID: 19289093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined quantitative (1)H and (13)C nuclear magnetic resonance spectroscopy for characterization of heparin preparations.
    Guerrini M; Bisio A; Torri G
    Semin Thromb Hemost; 2001 Oct; 27(5):473-82. PubMed ID: 11668416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of the oversulphated chondroitin sulphate contamination of unfractionated heparin by ATR-IR spectrophotometry.
    Norwig J; Beyer T; Brinz D; Holzgrabe U; Diller M; Manns D
    Pharmeur Sci Notes; 2009 Mar; 2009(1):17-24. PubMed ID: 19275869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants.
    Tami C; Puig M; Reepmeyer JC; Ye H; D'Avignon DA; Buhse L; Verthelyi D
    Biomaterials; 2008 Dec; 29(36):4808-14. PubMed ID: 18801571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.
    Trehy ML; Reepmeyer JC; Kolinski RE; Westenberger BJ; Buhse LF
    J Pharm Biomed Anal; 2009 Apr; 49(3):670-3. PubMed ID: 19167854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portable microcoil NMR detection coupled to capillary electrophoresis.
    Diekmann J; Adams KL; Klunder GL; Evans L; Steele P; Vogt C; Herberg JL
    Anal Chem; 2011 Feb; 83(4):1328-35. PubMed ID: 21235258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and use of a library of bona fide heparins employing 1H NMR and multivariate analysis.
    Rudd TR; Gaudesi D; Skidmore MA; Ferro M; Guerrini M; Mulloy B; Torri G; Yates EA
    Analyst; 2011 Apr; 136(7):1380-9. PubMed ID: 21279243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and detection of N-sulfonated oversulfated chondroitin sulfate in marketplace heparin.
    Mans DJ; Ye H; Dunn JD; Kolinski RE; Long DS; Phatak NL; Ghasriani H; Buhse LF; Kauffman JF; Keire DA
    Anal Biochem; 2015 Dec; 490():52-4. PubMed ID: 26278168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.